Consolidated Statements of Operations (Unaudited) (USD $) Share data in Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	$ 357,341	$ 1,105,004
Depreciation	184,884	245,996
Research and development (including stock-based compensation (Note 8))	66,586	66,558
Total operating expenses	608,811	1,417,558
Loss from operations	(608,811)	(1,417,558)
Other expense:
Interest expense	96,947	86,111
Other expense		1,918
	96,947	88,029
Net loss	(705,758)	(1,505,587)
Net loss attributable to the noncontrolling interest	1,071	1,294
Net loss attributable to Bion	(704,687)	(1,504,293)
Dividends on preferred stock	(500)	(500)
Net loss applicable to Bion's common stockholders	$ (705,187)	$ (1,504,793)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.04)	$ (0.08)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	19,817,076	18,055,025